I suspect that the Smorgon's block of stock was acquired by Eye Fund and passed onto DLS. People holding AQO will remember that a large chunk of stock was being used to cap the price for many months, then out of the blue, that stock was bought by Eye Fund at well above the going rate. I am sure whoever owned that stock felt very hard done by...and annoyed with AQO management.
I think this explains why the submission to the takeovers panel talks about DLS having pre-arranged agreement with Eye fund and the other major sharesholders.
p.s. I would expect a move on NSE eventually by Magnum. Its the only way they can get the other 52.5% of PEL 570. If they can acquire both AQO and NSE they can extinguish the $42.5 million agreement between both companies.
AQO Price at posting:
37.0¢ Sentiment: Buy Disclosure: Held
